The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation

Abstract

Aim: To study the effects of delayed and missed doses (poor compliance) on the pharmacokinetics of carbamazepine (CBZ) and its main active metabolite carbamazepine-10,11-epoxide (CBZE) in Chinese epilepsy patients using Monte Carlo simulation. Methods: CBZ and CBZE time-concentration profiles in various scenarios were generated based on a population pharmacokinetic study in Chinese epilepsy patients using Monte Carlo simulation. The scenarios included patients given multiple doses of CBZ that ranged from 100 to 300 mg three times daily or from 200 to 300 mg every 12 h. The therapeutic range of CBZ and CBZE for each scenario was estimated to assess the effect of delayed or missed doses and to design corresponding rescue regimens. Moreover, the impact of body weight, absorption rate and co-therapy with other antiepileptic drugs (phenytoin, phenobarbital and valproic acid) on the dosage recommendation was investigated in the event of poor compliance. Results: The risk for a sub-therapeutic range of CBZ and CBZE was increased in a dose-dependent manner in both two and three times daily regimens when delayed or missed doses occurred. The effects of poor compliance was less prominent on the lower daily doses compared with those on the higher daily doses. The dose recommendations, in the event of poor compliance, were time related and dose dependent. Patient body weight, absorption rate and co-therapy with phenytoin, phenobarbital and valproic acid had no significant impact on the dose recommendation. Conclusion: Patients with epilepsy should take the delayed doses as soon as they remember, and partial missed doses may need to be taken near or at the next scheduled time.

Minocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes

“…A preclinical study of BCP indicated that the drug only attenuated pain behavior at an early stage (from d 4 to d 6) by inhibiting microglia [44] ; however, an increasing number of therapeutic effects of the agent have been identified. In studies of CIPN, minocycline prevented CIPN-related symptoms and the activation of astrocytes despite the lack of microglial activation indicators [16][17][18][19] .…”

Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations

“…Computer simulation is a cost-effective means of systematically evaluating many different permutations of drug administration and has been used to evaluate the PK impact of irregular dosing for several AEDs in order to determine appropriate corrective actions [15][16][17][18][19]. For ease of illustration, the concentration-time profiles presented in our analysis depict the "typical patient" based on the population mean for each dosing scenario, similar to simulations comparing XR and IR formulations of lamotrigine [19].…”

Population Pharmacokinetic Evaluation and Missed‐Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial‐Onset Seizures

“…In a previous retrospective comparison, risk of seizure requiring hospital or emergency admission was 21% higher (hazard ratio = 1.205, P = .002) in nonadherent patients when compared to adherent patients . In addition, inappropriate resumption dose selection may result in higher than necessary drug concentrations and is a potential concern for toxicity . Although less frequent daily dosing typically results in better adherence (ie, QD dosing relative to higher dosing frequencies), delayed or missed doses can still be expected to occur in the treatment of epileptic patients.…”

“…Adherence to the prescribed AED regimen is an important issue in the control of seizures . The reported magnitude of nonadherence has ranged from 26% in the United States to 67% in Nigeria .…”